“…Reported data on the prevalence of anti-Hp antibodies in MS show considerable variation (Li et al, 2007, Long et al, 2013, Mohebi et al, 2013, Pedrini et al, 2015, Smyk et al, 2014, Wender, 2003. Thus, some authors found an increased frequency of anti-Hp antibodies in MS (Long et al, 2013), while others found a significantly lower prevalence of anti-Hp antibodies in MS compared to HCs…”